1: The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice
Ivan Tancevski, Egon Demetz, Philipp Eller, Kristina Duwensee, Julia Hoefer, Christiane Heim, Ursula Stanzl, Andreas Wehinger, Kristina Auer, Regina Karer, Julia Huber, Wilfried Schgoer, Miranda Van Eck, Jonathan Vanhoutte, Catherine Fievet, Frans Stellaard, Mats Rudling, Josef R. Patsch, Andreas Ritsch PLoS One. 2010; 5(1): e8722. Published online 2010 Jan 15. doi: 10.1371/journal.pone.0008722 PMCID: PMC2806908
2: The resurgence of thyromimetics as lipid-modifying agents I Tancevski, P Eller, JR Patsch, A Ritsch Curr Opin Investig Drugs. Author manuscript; available in PMC 2010 Nov 29.Published in final edited form as: Curr Opin Investig Drugs. 2009 Sep; 10(9): 912–918. PMCID: PMC2993058
3: THYROID HORMONE ANALOGUES FOR THE TREATMENT OF METABOLIC DISORDERS: NEW POTENTIAL FOR UNMET CLINICAL NEEDS? Timothy J. Shoemaker, Tatsuyoshi Kono, Cary N. Mariash, Carmella Evans-Molina Endocr Pract. Author manuscript; available in PMC 2013 Nov 1.Published in final edited form as: Endocr Pract. 2012 Nov-Dec; 18(6): 954–964. doi: 10.4158/EP12086.RA PMCID: PMC3745011
4: Potential role of two novel agonists of thyroid hormone receptor‐β on liver regeneration Andrea Perra, Marta Anna Kowalik, Lavinia Cabras, Massimiliano Runfola, Simona Sestito, Cristina Migliore, Silvia Giordano, Grazia Chiellini, Simona Rapposelli, Amedeo Columbano Cell Prolif. 2020 May; 53(5): e12808. Published online 2020 Apr 29. doi: 10.1111/cpr.12808 PMCID: PMC7260063
5: The thyromimetic T-0681 protects from atherosclerosis Ivan Tancevski, Andreas Wehinger, Egon Demetz, Julia Hoefer, Philipp Eller, Eva Huber, Ursula Stanzl, Kristina Duwensee, Kristina Auer, Wilfried Schgoer, Volker Kuhn, Catherine Fievet, Frans Stellaard, Mats Rudling, Bernhard Foeger, Josef R. Patsch, Andreas Ritsch J Lipid Res. 2009 May; 50(5): 938–944. doi: 10.1194/jlr.M800553-JLR200 PMCID: PMC2666180.